文章摘要
吴敏姣.米非司酮治疗子宫肌瘤68例临床分析[J].实用中西医结合临床,2006,(3):12-13
米非司酮治疗子宫肌瘤68例临床分析
  
DOI:
中文关键词: 米非司酮  子宫肌瘤  孕激素  临床分析
英文关键词: Mifepriston  Uterine Leimyoma  Progesterone  Clinical analysis
基金项目:
作者单位
吴敏姣 浙江省湖州市第一人民医院 
摘要点击次数: 566
全文下载次数: 276
中文摘要:
      目的:探讨米非司酮治疗子宫肌瘤的临床疗效。方法:子宫肌瘤68例口服米非司酮治疗,12.5mg,每日1次,睡前口服,连服3月;应用彩色超声监测治疗前后子宫肌瘤的变化,测定血清激素水平、肝肾功能、血红蛋白,观察服药后副反应。结果:68例患者在治疗期间均出现闭经,症状缓解。子宫体积平均缩小30.05%(P <0.01),肌瘤体积平均缩小44.56%(P <0.01)。治疗后E2、P平均水平较治疗前下降(P <0.01)。停药后34例患者子宫肌瘤逐渐增大,22例患者出现潮热、恶心等轻微副反应。结论:米非司酮治疗子宫肌瘤有一定疗效,副反应小,是一种有效的保守治疗方法,但停药后易复发。
英文摘要:
      Objectives:To investigate the effects of mifepristone treating Uterine Leigmyoma. Methods:68 cases with uterine Leimyoma were treated with mifepristone , 12.5 mg once a day before sleeping for 3 months . To observed change of uterine Leimyoma pre-treatment and past-treatment by color Ultrasound and measured serous hormone levels, liver and renal function, and hemoglobin , meanwhile, the side effects of drugs were assessed.Results:68 patients were amenorrhea with hemoylobin increasing during treatment . The mean level of serous Estrogen and progesterone dropped after treatment (P <0.01) . The percentage of the mean cubaye of uterus and uterine leimoyoma diminished 30.05% (P <0.01) and 44.56% (P <0.01) . The volume of Leimyoma increased among 34 Patients after stoping treatment . The side effects such an flash and nausea appeared among 22 patients. Conclusions:Mifepristone is effective against uterine Leiomyma with less side effect . It’s anacceptable conserative therapy , but the clinical symptoms are easy to recur after stopping treatment.
查看全文   查看/发表评论  下载PDF阅读器
关闭
手机扫一扫看
分享按钮